Relay Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Relay Therapeutics

02/11/2023 23:10

* Relay Therapeutics Inc  RLAY.OQ  reported a quarterly
adjusted
loss of 54 cents​​ per share for the quarter ended in September,
higher than the same quarter last year, when the company
reported EPS of -76 cents.  The mean expectation of
twelve analysts for the quarter was for a loss of 83 cents per
share. Wall Street expected results to range from -90 cents
to -67 cents per share.
    * Revenue rose 7,226.2% to $25.20 million from a year ago;
analysts expected $368.33 thousand. 
    * Relay Therapeutics Inc's reported EPS for the quarter was
a loss
of 54 cents​.
    * The company reported a quarterly loss of $65.73 million.
    * Relay Therapeutics Inc shares had fallen by 18.8% this
quarter and lost 54.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.2%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Relay
Therapeutics Inc is $26.50 
This summary was machine generated from LSEG data November 2 at
11:09 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -0.83          -0.54          Beat
 Jun. 30 2023      -0.82          -0.81          Beat
 Mar. 31 2023      -0.69          -0.78          Missed
 Dec. 31 2022      -0.70          -0.56          Beat